Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
PUT
Stryker
SYK
$133B
| $995K | ﹤0.01% |
5,600
+2,000
| +56% | +$341K |
|
3577
iShares US Home Construction ETF
ITB
$2.37B
| $990K | ﹤0.01% |
28,030
-41,270
| -60% | -$1.57M |
|
3578
Enovis
ENOV
$1.42B
| $989K | ﹤0.01% |
15,936
+13,524
| +561% | +$770K |
|
|
ABMD
3579
CALL
DELISTED
Abiomed Inc
ABMD
| $989K | ﹤0.01% |
2,200
+900
| +69% | +$355K |
|
3580
Lands' End
LE
$391M
| $988K | ﹤0.01% |
56,227
+6,718
| +14% | +$158K |
|
|
HOLX
3581
CALL
DELISTED
Hologic
HOLX
| $987K | ﹤0.01% |
24,100
-25,100
| -51% | -$1.01M |
|
3582
Penumbra
PEN
$12.9B
| $985K | ﹤0.01% |
6,578
-58,933
| -90% | -$8.25M |
|
3583
iShares S&P Small-Cap 600 Value ETF
IJS
$8.43B
| $984K | ﹤0.01% |
11,784
| – | – |
|
|
CMBT
3584
CMB.TECH NV
CMBT
$4.92B
| $983K | ﹤0.01% |
112,964
-4,903
| -4% | -$41.7K |
|
3585
LeMaitre Vascular
LMAT
$1.87B
| $982K | ﹤0.01% |
25,367
+4,669
| +23% | +$168K |
|
3586
PUT
PPG Industries
PPG
$25.5B
| $982K | ﹤0.01% |
9,000
-4,300
| -32% | -$469K |
|
3587
PUT
ProShares Ultra S&P500
SSO
$8.51B
| $982K | ﹤0.01% |
61,600
+18,400
| +43% | +$281K |
|
|
RTEC
3588
DELISTED
Rudolph Technologies Inc
RTEC
| $982K | ﹤0.01% |
40,168
+21,554
| +116% | +$594K |
|
3589
CALL
Toll Brothers
TOL
$13.9B
| $981K | ﹤0.01% |
29,700
-6,400
| -18% | -$232K |
|
|
HMHC
3590
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $981K | ﹤0.01% |
140,030
+95,860
| +217% | +$647K |
|
|
FTR
3591
CALL
DELISTED
Frontier Communications Corp.
FTR
| $981K | ﹤0.01% |
151,134
-300
| -0.2% | -$1.64K |
|
3592
PUT
Cognizant
CTSH
$26.2B
| $980K | ﹤0.01% |
12,700
-46,200
| -78% | -$3.61M |
|
3593
Tootsie Roll Industries
TR
$3.05B
| $980K | ﹤0.01% |
42,444
+37,455
| +751% | +$876K |
|
|
SEMG
3594
DELISTED
SEMGROUP CORPORATION
SEMG
| $980K | ﹤0.01% |
44,455
+30,891
| +228% | +$754K |
|
3595
PetMed Express
PETS
$43M
| $979K | ﹤0.01% |
29,664
+9,460
| +47% | +$354K |
|
3596
CALL
Energy Transfer Partners
ET
$72.1B
| $978K | ﹤0.01% |
56,100
+1,400
| +3% | +$24.9K |
|
3597
CALL
PTC Therapeutics
PTCT
$6.06B
| $978K | ﹤0.01% |
20,800
-101,700
| -83% | -$4.21M |
|
3598
CALL
Annaly Capital Management
NLY
$17.4B
| $977K | ﹤0.01% |
23,875
-2,775
| -10% | -$116K |
|
|
PTR
3599
PUT
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $977K | ﹤0.01% |
12,000
+7,100
| +145% | +$529K |
|
3600
Axcelis
ACLS
$4.39B
| $976K | ﹤0.01% |
49,624
+31,038
| +167% | +$639K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.